Patents by Inventor David Paul D. Woldbye

David Paul D. Woldbye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEUROPEPTIDE Y-DERIVED PEPTIDES
    Publication number: 20190002517
    Abstract: The present invention discloses peptide fragments derived from neuropeptide Y (NPY), which are capable of selective binding to the neural cell adhesion molecule (NCAM) and inducing neuroplastic and neuroprotective effects, and the use of said peptide fragments as neuritogenic agents for treatment of pathological conditions in which neuroprotection and neuroplastic changes are desired, such as brain and retina disorders.
    Type: Application
    Filed: June 13, 2018
    Publication date: January 3, 2019
    Inventors: David-Paul D. Woldbye, Casper Rene Gøtzsche, Kristian Klemp, Vladimir Berezin, Elisabeth Bock
  • Neuropeptide Y-derived peptides
    Patent number: 10017554
    Abstract: The present invention discloses peptide fragments derived from neuropeptide Y (NPY), which are capable of selective binding to the neural cell adhesion molecule (NCAM) and inducing neuroplastic and neuroprotective effects, and the use of said peptide fragments as neuritogenic agents for treatment of pathological conditions in which neuroprotection and neuroplastic changes are desired, such as brain and retina disorders.
    Type: Grant
    Filed: April 10, 2014
    Date of Patent: July 10, 2018
    Assignees: University of Copenhagen, Næstved Hospital
    Inventors: David Paul D. Woldbye, Casper Rene Gøtzsche, Kristian Klemp, Vladimir Berezin, Elisabeth Bock
  • NEUROPEPTIDE Y-DERIVED PEPTIDES
    Publication number: 20160060320
    Abstract: The present invention discloses peptide fragments derived from neuropeptide Y (NPY), which are capable of selective binding to the neural cell adhesion molecule (NCAM) and inducing neuroplastic and neuroprotective effects, and the use of said peptide fragments as neuritogenic agents for treatment of pathological conditions in which neuroprotection and neuroplastic changes are desired, such as brain and retina disorders.
    Type: Application
    Filed: April 10, 2014
    Publication date: March 3, 2016
    Applicants: NÆSTVED HOSPITAL, UNIVERSITY OF COPENHAGEN
    Inventors: David Paul D. Woldbye, Casper Rene Gøtzsche, Kristian Klemp, Vladimir Berezin, Elisabeth Bock